Fourth, previous studies have suggested that CSF3R mutations adversely impact PFS in CEBPA double‐mutant AML; however, their prognostic significance for OS in AML patients remains controversial [6, 7, 8, 9, 10]. Here, CSF3R is linked to acute myeloid leukemia.